Mylan (Switzerland)

Mylan (Switzerland)

Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Mylan (Switzerland), Switzerland, covering academic research published from 2000 to 2022. Read More.


Open Access Percentage

51%


Total
Publications

1.5K


Total Open
Publications

762


Total
Citations

59K


Open Access
Percentage

51%


Total
Publications

1.5K


Total Open
Publications

762


Total
Citations

59K

Wikipedia

Website

download

Breakdown

19% 16% 16% 49%

Publisher Open

19%

Both

16%

Other Platform Open

16%

Closed

49%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022

Open

Closed

Publisher Open

23%OA Journal

OA Journal 23%

120

Hybrid 50%

259

No Guarantees 27%

140

Other Platform Open

Institution 73%

356

Domain 28%

134

Other Internet 16%

80

Public 15%

71

Preprint 7%

33

Other Platform Locations

Name

Platform Type

Publications

Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca
Institution
133
PubMed Central
Domain
129
University of Castilla La Mancha - Virtual Community of Pathological Anatomy
Institution
97
Europe PMC
Domain
88
Semantic Scholar
Public
63
University of Milano-Bicocca - BOA - Bicocca Open Archive
Institution
45
INFN Catania - INFM-OAR
Other Internet
35
University College London - UCL Discovery
Institution
25
arXiv
Preprint
18
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
11
1 / 15

Data updated 15 November 2023

Share

Share

Share